LINKEDINCOMMENTMORE

(CBS) The FDA is approving Perjeta, a drug proven to shrink tumors before surgery in breast cancer patients. CBS News contributor Dr. David Agus joins the CBS This Morning co-hosts to discuss the promising drug.

Read or Share this story: http://www.khou.com/story/news/health/2014/07/23/12147458/